CALYPTE BIOMEDICAL CORP Deferred Tax Assets, Net of Valuation Allowance
CALYPTE BIOMEDICAL CORP had Deferred Tax Assets, Net of Valuation Allowance of $0 as of 2012-12-31, per its 10-K filed 2014-06-24.
Discontinued › Notes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2014-06-24
- 2012-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
- 2011-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2012-12-31 | $0.00 10-K · filed 2014-06-24 |
| 2011-12-31 | $0.00 10-K · filed 2014-06-24 |